Medication info

Sidabec 100 mg (Sitagliptin Hydrochloride Hydrate)

Prescription medicationTabletOralExpired
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›113.4mg / 1 tablet
Manufacturer / importer
Gunil Biopharm Co., Ltd.
Appearance
Light orange, round, bilayer, convex film-coated tablet
Packaging
28 tablets/box [14/PTP x 2]
Approval status
Expired

MFDS item code 202100088 · Approved 2021.01.06

This product's status changed to Expired on 2026.01.06. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer 100 mg of sitagliptin once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia induced by the sulfonylurea or insulin (see Precautions for Use, section 5. General Precautions). Patients with renal impairment Because dosage adjustment based on renal function is required, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. 1. No dosage adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered without regard to the timing of dialysis.

Ingredients

Manufacturer
Gunil Biopharm Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used to improve blood sugar control in patients with type 2 diabetes. It may be administered alone at the start of treatment, or in combination with metformin if blood sugar control is inadequate with monotherapy. Furthermore, if sufficient control is not achieved with other monotherapies like sulfonylureas, metformin, thiazolidinediones, or insulin, this medication is utilized to enhance the effect. For various combination therapies where blood sugar control is insufficient, additional administration of sitagliptin is helpful for blood sugar management. This medication is a valuable treatment option for managing type 2 diabetes.

How to take

Adult dose

Administer 100 mg of sitagliptin once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia induced by the sulfonylurea or insulin (see Precautions for Use, section 5. General Precautions). Patients with renal impairment Because dosage adjustment based on renal function is required, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. 1. No dosage adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered without regard to the timing of dialysis.

Precautions

This medication is used for the treatment of diabetes and there are several precautions to consider while taking it. First, severe allergic reactions may occur during the use of this medication, so if symptoms such as skin rash, swelling, or difficulty breathing occur, discontinue use immediately and consult a doctor. Second, this medication can cause serious side effects such as pancreatitis, which is inflammation of the pancreas; therefore, if symptoms like abdominal pain, vomiting, or nausea appear, inform healthcare providers immediately. Third, this medication should not be used by patients with type 1 diabetes or diabetic ketoacidosis. Fourth, patients with decreased kidney function may have difficulties with drug excretion, requiring dose adjustments and regular kidney function tests. Fifth, when taken with other hypoglycemic agents or insulin, the risk of hypoglycemia may increase, so be attentive to symptoms of hypoglycemia and adjust doses of other medications as needed. Sixth, some patients may experience side effects such as joint pain or skin diseases, so it is important to consult with a physician if symptoms appear. Seventh, it is not recommended for women who are pregnant or nursing, and for children under 18 years, as the safety of this medication has not been established. Finally, if overdose occurs, visit a medical facility immediately for appropriate treatment, as this medication can be partially removed through hemodialysis, which should be considered for patients with severely impaired kidney function.

Side effects

  • Severe hypersensitivity reactions
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory infection
  • nasopharyngitis
  • headache
  • diarrhea
Show 28 more
  • abdominal pain
  • nausea
  • constipation
  • vomiting
  • severe and debilitating arthralgia
  • blistering similar to pemphigus
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • pneumonia
  • diabetic complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased serum triglycerides
  • gastritis
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air entry, and it is best to keep it at room temperature between 1 degree and 30 degrees. This helps maintain the effectiveness of the medicine.

Appearance and packaging

Appearance

Light orange, round, bilayer, convex film-coated tablet

Package unit

28 tablets/box [14/PTP x 2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.